BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35123444)

  • 1. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey.
    Ateudjieu J; Yakum MN; Goura AP; Tembei Ayok M; Guenou E; Kangmo Sielinou CB; Kiadjieu FF; Tsafack M; Douanla Koutio IM; Tchio-Nighie KH; Tchokomeni H; Ntsekendio PN; Sack DA
    BMC Public Health; 2022 Feb; 22(1):238. PubMed ID: 35123444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
    Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
    BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
    Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey.
    Ngwa MC; Alemu W; Okudo I; Owili C; Ugochukwu U; Clement P; Devaux I; Pezzoli L; Oche JA; Ihekweazu C; Sack DA
    BMJ Glob Health; 2020 Jun; 5(6):. PubMed ID: 32601092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
    Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L
    PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
    Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
    Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
    Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
    PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage survey and lessons learned from a pre-emptive cholera vaccination campaign in urban and rural communities affected by landslides and floods in Freetown Sierra Leone.
    Gelormini M; Gripenberg M; Marke D; Murray M; Yambasu S; Koblo Kamara M; Michael Thomas C; Donald Sonne K; Sang S; Kayita J; Pezzoli L; Caleo G
    Vaccine; 2023 Mar; 41(14):2397-2403. PubMed ID: 36872143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
    Lubogo M; Mohamed AM; Ali AH; Ali AH; Popal GR; Kiongo D; Bile KM; Malik M; Abubakar A
    Vaccine; 2020 Feb; 38 Suppl 1():A141-A147. PubMed ID: 31980193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi.
    Ilboudo PG; Le Gargasson JB
    BMC Infect Dis; 2017 Dec; 17(1):779. PubMed ID: 29258447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
    Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
    Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
    [No Abstract]   [Full Text] [Related]  

  • 14. Global oral cholera vaccine use, 2013-2018.
    Pezzoli L;
    Vaccine; 2020 Feb; 38 Suppl 1(Suppl 1):A132-A140. PubMed ID: 31519444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
    Teshome S; Desai S; Kim JH; Belay D; Mogasale V
    Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda.
    Bwire G; Roskosky M; Ballard A; Brooks WA; Okello A; Rafael F; Ampeire I; Orach CG; Sack DA
    BMJ Open; 2020 Dec; 10(12):e038464. PubMed ID: 33303438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cholera vaccination coverage after the first global stockpile deployment in Haiti, 2014.
    Burnett EM; Francois J; Sreenivasan N; Wannemuehler K; Faye PC; Tohme RA; Delly P; Deslouches YG; Etheart MD; Dismer AM; Patel R; Date K
    Vaccine; 2019 Oct; 37(43):6348-6355. PubMed ID: 31521413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cholera vaccination coverage following emergency campaign in Haiti: Results from a cluster survey in three rural Communes in the South Department, 2017.
    Sharp A; Blake A; Backx J; Panunzi I; Barrais R; Nackers F; Luquero F; Deslouches YG; Cohuet S
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007967. PubMed ID: 32004316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
    Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
    BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.